PERSPECTA

News from every angle

← Back to headlines

Drug Pricing Policy and Eli Lilly Concentration Identified as Key Risks for PPH ETF in 2026

An analysis of the PPH ETF highlights drug pricing policy and the market concentration of pharmaceutical giant Eli Lilly as two significant risks for investors to monitor in 2026.

28 Mar, 11:15 — 28 Mar, 11:15
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual15d ago

PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026

Read full article →

Related Stories

Study Suggests Syphilis-Like Disease Spread in Ancient Vietnam, Challenging Columbus Theory

just now

Padel for Parkinson’s Cycling Event Held at University of Ghana for Awareness

12m ago

Understanding and Managing Postpartum Sweating

23m ago

Protecting Dogs from Viper Bites as Weather Warms

36m ago